Breast cancer in young women: prevalence of LOH at p53, BRCA1 and BRCA2

被引：0
|
作者：
SM Johnson
JA Shaw
RA Walker
机构：
[1] University of Leicester,Breast Cancer Research Unit
[2] Clinical Sciences,undefined
[3] Glenfield Hospital,undefined
来源：
Breast Cancer Research | / 2卷 / Suppl 1期
关键词：
Breast Cancer; Paraffin; Young Woman; Pathological Feature; Full Text;
D O I：
10.1186/bcr96
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer
    Song, Chuan-Gui
    Hu, Zhen
    Wu, Jiong
    Luo, Jian-Min
    Shen, Zhen-Zhou
    Huang, Wei
    Shao, Zhi-Ming
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (10) : 617 - 626
  • [2] The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer
    Chuan-Gui Song
    Zhen Hu
    Jiong Wu
    Jian-Min Luo
    Zhen-Zhou Shen
    Wei Huang
    Zhi-Ming Shao
    Journal of Cancer Research and Clinical Oncology, 2006, 132 : 617 - 626
  • [3] The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapy
    Golshan, M
    Miron, A
    Nixon, AJ
    Garber, JE
    Cash, EP
    Iglehart, JD
    Harris, JR
    Wong, JS
    AMERICAN JOURNAL OF SURGERY, 2006, 192 (01) : 58 - 62
  • [4] Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and P53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers
    Kontorovich, Tair
    Cohen, Yoram
    Nir, Uri
    Friedman, Eitan
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 116 (01) : 195 - 200
  • [5] BRCA1 and BRCA2 in hereditary breast cancer
    Scully, R
    Puget, N
    BIOCHIMIE, 2002, 84 (01) : 95 - 102
  • [6] Oophorectomy for breast cancer prevention in women with BRCA1 or BRCA2 mutations
    Metcalfe, Kelly A.
    WOMENS HEALTH, 2009, 5 (01) : 63 - 68
  • [7] Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
    Kotsopoulos, Joanne
    Gronwald, Jacek
    Huzarski, Tomasz
    Aeilts, Amber
    Armel, Susan Randall
    Karlan, Beth
    Singer, Christian
    Eisen, Andrea
    Tung, Nadine
    Olopade, Olufunmilayo
    Bordeleau, Louise
    Eng, Charis
    Foulkes, William
    Neuhausen, Susan
    Cullinane, Carey
    Pal, Tuya
    Fruscio, Robert
    Lubinski, Jan
    Metcalfe, Kelly
    Sun, Ping
    Narod, Steven
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (02) : 257 - 264
  • [8] Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
    Joanne Kotsopoulos
    Jacek Gronwald
    Tomasz Huzarski
    Amber Aeilts
    Susan Randall Armel
    Beth Karlan
    Christian F. Singer
    Andrea Eisen
    Nadine Tung
    Olufunmilayo Olopade
    Louise Bordeleau
    Charis Eng
    William D. Foulkes
    Susan L. Neuhausen
    Carey A. Cullinane
    Tuya Pal
    Robert Fruscio
    Jan Lubinski
    Kelly Metcalfe
    Ping Sun
    Steven A. Narod
    Breast Cancer Research and Treatment, 2023, 201 : 257 - 264
  • [9] Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer
    Chappuis, PO
    Hamel, N
    Paradis, AJ
    Deschênes, J
    Robidoux, A
    Potvin, C
    Cantin, J
    Tonin, P
    Ghadirian, P
    Foulkes, WD
    CLINICAL GENETICS, 2001, 59 (06) : 418 - 423
  • [10] Diabetes and Breast Cancer Among Women With BRCA1 and BRCA2 Mutations
    Bordeleau, Louise
    Lipscombe, Lorraine
    Lubinski, Jan
    Ghadirian, Parviz
    Foulkes, William D.
    Neuhausen, Susan
    Ainsworth, Peter
    Pollak, Michael
    Sun, Ping
    Narod, Steven A.
    CANCER, 2011, 117 (09) : 1812 - 1818
12345